Biomet Enhances Spend Visibility With Ariba
Ariba, Inc. (Nasdaq:ARBA), the leading spend management solutions provider, today announced that it has signed a new agreement with Biomet, Inc. (NASDAQ:BMET). A worldwide leader in the design and manufacture of joint replacement products, Biomet will use Ariba® Spend Visibility™ On-Demand Professional to gain a better view into what it is spending and with whom, identify opportunities for savings and drive them to the bottom line.
“For nearly three decades, Biomet has applied advanced technology to the development of our products. Now, we are taking the same approach with our operations,” said Gary Bird, Purchasing Manager, Biomet. “In adopting and implementing Ariba Spend Visibility, we can gain a clear and centralized view into our spend that will allow us to streamline our supply base, enhance our sourcing process and ultimately, improve our cost structure.”
A powerful combination of technology, services and knowledge, Ariba Spend Visibility provides companies with ongoing visibility into and control of spend across all categories, systems, and divisions throughout their entire procure-to-pay cycle. The solution’s wide deployability and easy-to-use interface gives decision makers rapid access to meaningful intelligence regarding spend, supplier performance and procurement processes.
“Through its commitment to innovation and change, Biomet has established itself as a leader in a highly competitive market,” said Ken Miklos, Product Manager, Ariba Spend Visibility. “With Ariba Spend Visibility, Biomet can access information that enables it to develop informed sourcing strategies, fully leverage preferred suppliers, better monitor compliance, and ultimately, ensure its future success.”
About Biomet
Biomet, Inc. (NASDAQ:BMET) and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses reconstructive products, including orthopedic joint replacement devices, bone cements and accessories, autologous therapies and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in more than 100 countries.
About Ariba, Inc.
Ariba, Inc. is the leading provider of spend management solutions to help companies realize rapid and sustainable bottom line results. Successful companies around the world in every industry use Ariba Spend Management™ software and services. Ariba can be contacted in the U.S. at 1.650.390.1000 or at www.ariba.com.
Copyright © 1996 — 2007 Ariba, Inc.
Ariba, the Ariba logo, AribaLIVE and SupplyWatch are registered trademarks of Ariba, Inc. Ariba Spend Management, Ariba Spend Management. Find it. Get it. Keep it., Ariba. This is Spend Management, Ariba Solutions Delivery, Ariba Analysis, Ariba Buyer, Ariba Category Management, Ariba Category Procurement, Ariba Contract Compliance, Ariba Contracts, Ariba Contract Management, Ariba Contract Workbench, Ariba Data Enrichment, Ariba eForms, Ariba Electronic Invoice Presentment and Payment, Ariba Invoice, Ariba Sourcing, Ariba Spend Visibility, Ariba Travel and Expense, Ariba Procure-to-Pay, Ariba Workforce, Ariba Supplier Network, Ariba Supplier Connectivity, Ariba Supplier Performance Management, Ariba PunchOut, Ariba QuickSource, PO-Flip, Ariba Settlement, Ariba Spend Management Knowledge Base, Ariba Ready, Ariba Supply Lines, Ariba Supply Manager, Ariba LIVE and It’s Time for Spend Management are trademarks or service marks of Ariba, Inc. Ariba Proprietary and Confidential. All rights reserved. Patents pending. All other trademarks are property of their respective owners.
Ariba Safe Harbor
Safe Harbor Statement under the Private Securities Litigation Reform Act 1995: Information and announcements in this release involve Ariba’s expectations, beliefs, hopes, plans, intentions or strategies regarding the future and are forward-looking statements that involve risks and uncertainties. All forward-looking statements included in this release are based upon information available to Ariba as of the date of the release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to Ariba’s operating and financial results to differ materially from its current expectations include, but are not limited to: delays in development or shipment of new versions of Ariba’s products and services; lack of market acceptance of Ariba’s existing or future products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; the ability to attract and retain qualified employees; difficulties in assimilating acquired companies; long and unpredictable sales cycles and the deferrals of anticipated orders; declining economic conditions; inability to control costs; changes in the company’s pricing or compensation policies; significant fluctuations in our stock price; the outcome of and costs associated with pending or potential future regulatory or legal proceedings; the impact of our acquisitions, including the disruption or loss of customer, business partner, supplier or employee relationships; and the level of costs and expenses incurred by Ariba as a result of such transactions. Factors and risks associated with its business, including a number of the factors and risks described above, are discussed in Ariba’s Form 10-Q filed August 8, 2007.